JACQUELINE HALE: Open Payments
NPI 1952779712 · SUMMIT, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,978 in 81 payments from 20 companies in 2025. Trend: 2023 $1,447 · 2024 $1,729 · 2025 $1,978
Food & beverage: $1,843Education: $135
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $412 |
| Otsuka America Pharmaceutical, Inc. | 7 | $233 |
| Calliditas Therapeutics US Inc. | 5 | $202 |
| ANI Pharmaceuticals, Inc. | 6 | $179 |
| Amgen Inc. | 8 | $158 |
| OPKO Pharmaceuticals, LLC | 6 | $135 |
| Travere Therapeutics, Inc. | 1 | $111 |
| Mallinckrodt Hospital Products Inc. | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| GlaxoSmithKline, LLC. | 3 | $58 |
Products named: Fabhalta, TARPEYO, PURIFIED CORTROPHIN GEL, RAYALDEE, JYNARQUE, Filspari, KRYSTEXXA, ACTHAR.
Industry payments across WI — which companies pay providers there.
